LRRK2 and Parkinson disease: Similarly, mutations in the gene LRRK2 account for 5%–6% of patients with familial Parkinsons Disease (PD) and 1%–3% of sporadic cases, but most LRRK2 mutant transgenic mouse models showed minimal or no neurodegeneration (Xu et al., 2012).